Supporting Drug Development in ALS Through the Use of Digital Health Technologies

Time: 2:00 pm
day: Day One Track B PM


  • Discussing ALS signs and symptom domain assessments with Digital Health Technologies (DHTs)
  • Understanding the role DHTs can play in drug development tools (including COAs, biomarkers, and models/methodologies)
  • Discussing the potential of DHTs to support quicker and more consistent diagnoses, and progression, and enabling targeted interventions at earlier stages through patient selection